IKRA ASHRAFI: Open Payments
NPI 1740996263 · GRAPEVINE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$505 in 23 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $616 · 2025 $505
Food & beverage: $505
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $70 |
| Janssen Pharmaceuticals, Inc | 3 | $67 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
| Almatica Pharma LLC | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Lundbeck LLC | 2 | $36 |
| Alkermes, Inc. | 2 | $36 |
| Soleno Therapeutics, Inc. | 1 | $32 |
| Bausch Health US, LLC | 1 | $23 |
| Noven Therapeutics, LLC | 1 | $22 |
Products named: INVEGA SUSTENNA, COBENFY, REXULTI, LOREEV XR, AUSTEDO XR, VYKAT XR, UZEDY, ABILIFY MAINTENA.
Industry payments across TX — which companies pay providers there.
